Results
59
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
59 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TPT | UK£0.35 | -5.0% | -22.4% | UK£68.8m | UK£0.60 | PS0.3x | E77.9% | 6.9% | Retail | ||
CRW | UK£21.00 | 11.7% | -1.9% | UK£735.4m | UK£28.33 | PE78.2x | E29.6% | 1.4% | Healthcare | ||
LIKE | UK£0.18 | -3.9% | -6.1% | UK£45.6m | n/a | PE45.4x | E48.5% | 2.0% | Retail | ||
GLE New | UK£4.79 | -2.3% | -5.8% | UK£279.6m | UK£6.67 | PE16.9x | E20.3% | 2.3% | Consumer Durables | ||
TRX | UK£0.54 | -9.3% | -15.1% | UK£38.1m | UK£1.20 | PS1.5x | E170.8% | n/a | Pharmaceuticals & Biotech | ||
CLIG | UK£3.62 | 4.9% | 0.1% | UK£176.8m | n/a | PE13x | E25.4% | 8.8% | Diversified Financials | ||
CLX | UK£0.61 | -10.9% | -25.2% | UK£53.6m | UK£1.09 | PS3.4x | E95.8% | 1.5% | Tech | ||
LLAI | UK£0.018 | -7.5% | -95.9% | UK£567.2k | UK£1.71 | PS24.6x | E101.0% | n/a | Pharmaceuticals & Biotech | ||
AML | UK£1.12 | 4.2% | -33.8% | UK£1.1b | UK£1.43 | PS0.7x | E60.4% | n/a | Automobiles | ||
KIST | UK£1.38 | 6.6% | -1.4% | UK£114.4m | UK£2.77 | PS0.7x | E111.7% | n/a | Energy | ||
BGO | UK£0.99 | 0% | -12.0% | UK£76.1m | UK£2.32 | PS1.9x | E119.5% | n/a | Software |